Health Tech Forum - Aug. 24
Researcher & best-selling author, Dr. David Fajgenbaum, on repurposing approved drugs
Dr. David Fajgenbaum, a graduate of Georgetown University, University of Oxford and the University of Pennsylvania Medical School and the Wharton School, makes time for Tech Titans. He is a groundbreaking physician-scientist spearheading an international effort to identify COVID19 treatments, and author of the national bestselling memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action.
Dr. Fajgenbaum is among the top 1% of the youngest awardees of a leading NIH grant (R01), recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. He has published scientific papers in high-impact journals such as the New England Journal of Medicine, Lancet Haematology, and the Journal of Clinical Investigation, including a paper selected as one of the top innovations in science and medicine by STAT News in 2020. He has been profiled by Good Morning America, CNN, and the Today Show, among others.
Profiled in the New York Times as the 'doctor who cured himself' (Doctor Cure Thyself, NY Times), David went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a treatment that is saving his life and others.
Now, he is spreading this approach to other diseases as one of the youngest individuals ever named to the faculty at Penn Medicine and leading an international effort in partnership with the FDA and Google Health to identify treatments for COVID19 and other conditions by looking at already approved compounds.